Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Babcock reiterates outlook on strong first half

(Sharecast News) - Defence contractor Babcock International reaffirmed its full-year outlook on Thursday after an "encouraging" start to the year. Updating on trading, the blue chip said organic revenue growth and underlying operating margin progress had both been in line with expectations in the five months to August end.

Its nuclear and aviation divisions performed particularly well. In nuclear, it secured a £114m contract to the support the defueling of a decommissioned British submarine over 20 years, while aviation benefited from the ramp up of the French Mentor 2 contract.

Babcock also secured an eight-year contract with the Australian Border Force, to enhance maritime security operations in the Torres Strait.

The strong performances in nuclear, aviation and marine helped offset lower revenues in land, which were impacted by weaker activity in rail.

The firm said: "Trading in the first five months has been encouraging.

"Overall, expectations for the full year remain unchanged, and we continue to progress towards the group's medium-term guidance.

"The macro environment remains supportive, and we continue to make good strategic progress."

As at 1045 BST shares in the blue chip were down 2%, at 1,206

Russ Mould, investment director at AJ Bell, said: "The uncertain geopolitical backdrop and push for European countries to boost defence spending have seen Babcock score as one of the top performers in the FTSE 100 this year.

"The negative response to what is a fairly run-of-the-mill and in-line trading update must be seen in this context, with the shares pausing for breath after more than doubling so far in 2025.

"Not many businesses can call the macro environment supportive right now, but in an increasingly fractious world, Babcock is one."

Babcock was updating investors at its annual general meeting. It is due to publish interim results on 20 November.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.